Deprescribing in CKD: The Proof Is in the Process

Deprescribing has garnered attention in the literature and medical community as a strategy to address the growing polypharmacy epidemic. According to the National Health and Nutrition Examination Survey, prescription drug use and polypharmacy increased across all adult age groups from 1999 to 2012.1 Polypharmacy is linked to increased risk for adverse drug events, more frequent emergency department visits and hospitalizations, and increased health care costs.1,2

http://ift.tt/2grw95Z